Clofibrate and Atherosclerosis
- 1 March 1979
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 300 (9) , 491-492
- https://doi.org/10.1056/nejm197903013000911
Abstract
Despite a variety of efforts aimed at altering its course, atherosclerosis and its sequelae are still major causes of death in the United States and other industrialized nations. In the absence of a single, clearcut etiologic agent, therapeutic interventions have focused on the known multiple risk factors for atherosclerosis, including hypercholesterolemia, hypertension, smoking and diabetes mellitus, If atherosclerosis were an acute disease, easily detected and followed, with a clear-cut outcome in a short time, it would be relatively simple to evaluate the effects of interventions designed to alter its progression. It is, on the contrary, a chronic, relapsing and remitting . . .Keywords
This publication has 4 references indexed in Scilit:
- Cholesterol, Coronaries, Clofibrate and DeathNew England Journal of Medicine, 1978
- A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.Heart, 1978
- Therapy of the hyperlipidemiasPostgraduate Medicine, 1976
- Clofibrate and niacin in coronary heart diseaseJAMA, 1975